Reversing macular degeneration

Julia Busch

Reversing macular degeneration

The leading cause of blindness in older adults the most common degenerative condition affecting the retina is age-related macular degeneration (ARMD). It targets the retina’s central portion, the macula, which is responsible for sharp central vision. As the disease progresses, all retinal cells are affected, including connective tissue blood vessels.

In later stages, decreased blood flow to deterioration in the structure of the retina can cause bleeding exudative (wet) macular degeneration. In its most advanced forms, the effects are so severe that one becomes unable to read, drive, watch TV, recognize a face even walk across a room without tripping.

The underlying cause appears to be a genetic abnormality in the ATP-binding cassette transporter gene (ABCR). The defect is also linked to fundus flavimaculatus (FFM), retinitis pigmentosa (RP), cone dystrophy (COD) cone-rod dystrophy (CRD).

Amazingly, though, clinical studies show that a highly sophisticated microcurrent (MCS) device, which emits specific, low-current bioelectrical waves, can significantly improve diseased retinas in a very high percentage of wet dry ARMD cases their juvenal counterpart, Stargart’s disease (STDG).

MCS stimulation improves cellular metabolism blood flow to promote retinal healing. Of 120 patients treated in a California clinic, 100 percent of the 11 with Stargardt’s Disease and 88 percent of those with wet (43 out of 49) and 77 percent (46 out of 60) with dry ARMD showed improvement greater than, equal to, two lines on an eye chart in one both eyes, via visual acuity testing. Improvement in visual fields color vision testing was also reported.

MCS treatments are required only several minutes daily to a few times weekly. These at-home, hand-held, units (about the size of an iPod) are painless, easy-to-use, require just three four five-minute sessions. The units appear to be remarkably safe. However, treatment must be ongoing for improvement stabilization to continue.

Resource: ABCR Unites What Ophthalmologists Divide, van Driel, M.A., et al, Ophthalmic Genetetics, 1998 Sep;19(3):117-22) Smoking, diet, lifestyle, other eye problems can influence development, severity, how early ARMD shows itself.

Reprinted from AzNetNews, Volume 25, Number 5, October/November 2006.

Found this helpful? Share it with someone who needs it.